S&P 500
(0.12%) 5 303.27 points

Dow Jones
(0.34%) 40 004 points

Nasdaq
(-0.07%) 16 686 points

Oil
(0.19%) $80.21

Gas
(1.49%) $2.67

Gold
(0.75%) $2 435.50

Silver
(4.05%) $32.53

Platinum
(0.94%) $1 100.20

USD/EUR
(-0.03%) $0.920

USD/NOK
(-0.12%) $10.66

USD/GBP
(0.01%) $0.787

USD/RUB
(0.09%) $91.05

Realtime updates for Gensight Biologics SA [SIGHT.PA]

Exchange: EURONEXT Industry: Biotechnology

Last Updated17 May 2024 @ 11:35

25% discount on Stockinvest.us - Use code: Podcast

-2.72% € 0.394

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 11:35):

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system...

Stats
Today's Volume	73 102.00
Average Volume	139 521
Market Cap	40.00M
EPS	€0 ( 2024-03-26 )
Next earnings date	( €0 ) 2024-05-29
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-0.730
ATR14	€0.00200 (0.51%)

Gensight Biologics SA Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Gensight Biologics SA Correlation - Currency/Commodity

0.00
( neutral )

-0.14
( neutral )

0.00
( neutral )

0.00
( neutral )

0.00
( neutral )

0.53
( weak )

Gensight Biologics SA Financials

Annual	2023
Revenue:	€1.27M
Gross Profit:	€3.00M (236.78 %)
EPS:	€-0.540

FY	2023
Revenue:	€1.27M
Gross Profit:	€3.00M (236.78 %)
EPS:	€-0.540

FY	2022
Revenue:	€2.58M
Gross Profit:	€2.58M (100.00 %)
EPS:	€-0.600

FY	2021
Revenue:	€5.28M
Gross Profit:	€0.00 (0.00 %)
EPS:	€-0.630

Financial Reports:

No articles found.

Gensight Biologics SA Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Gensight Biologics SA

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.